Vasculitis clinical trials
The registry lists 230 studies for Vasculitis across more than 10 countries. 68 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-11.
Status
- Completed
- 91
- Recruiting
- 57
- Status unknown
- 39
- Terminated
- 17
- Not yet recruiting
- 9
- Active, not recruiting
- 9
Phase
- Phase 2
- 42
- Phase 3
- 28
- Phase 1
- 21
- Phase 4
- 15
- Early Phase 1
- 2
Where
- United States
- 77
- France
- 48
- United Kingdom
- 35
- China
- 29
- Canada
- 21
- Germany
- 18
Who runs them
Assistance Publique - Hôpitaux de Paris (20) · National Institute of Allergy and Infectious Diseases (NIAID) (11) · Amgen (10) · University of Pennsylvania (10) · Cambridge University Hospitals NHS Foundation Trust (7) · University of South Florida (6) · University of Edinburgh (5) · Novartis Pharmaceuticals (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 230 — search for more.
- JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint InhibitorsRecruitingNCT042947711 country
- Benralizumab Effectiveness in EGPARecruitingNCT078158861 country
- Pragmatic, Open-Label Study to Pilot Evaluation for Clinical Trials in Relapsing PolychondritisRecruitingNCT06941376Phase 21 country
- Mass Spectrometry-based Immune Profiling in Autoimmune DiseasesEnrolling by invitationNCT071882851 country
- Pain-Sleep in Rheumatic DiseaseNot yet recruitingNCT07775612Not applicable
- Abatacept for the Treatment of Giant Cell ArteritisRecruitingNCT04474847Phase 33 countries
- Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting Agent in the Treatment of Hypersensitivity Reaction (IgA) VasculitisRecruitingNCT07595367Phase 22 countries
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 21 country
- A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO TrialRecruitingNCT05946564Phase 31 country
- Ocular Manifestations of Granulomatosis With Polyangiitis.RecruitingNCT076647091 country
- Mapping B-cell Biology Across the Cardiovascular Territories of Giant Cell Arteritis: Towards a New Therapeutic Approach (RituxiMAP GCA)Not yet recruitingNCT072699381 country
- Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated VasculitisRecruitingNCT07160608Phase 214 countries
- Infliximab Therapy for Dolichoectactic Vertebrobasilar AneurysmsRecruitingNCT02638701Phase 1/21 country
- SysteMic vAsculitis pRognosis and ouTcomeRecruitingNCT075861371 country
- The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic ConditionsRecruitingNCT072786091 country
- Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic SettingRecruitingNCT050120331 country
- Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune DiseasesRecruitingNCT052514151 country
- Role of Vessel Wall MRI in Differentiaition Between Intracranial Atherosclerotic Disease and Vasculitis as Causes of Ischemic StrokeNot yet recruitingNCT07448454Not applicable
- Cardiac Imaging in Systemic Disorders: the ORACLES RegistryNot yet recruitingNCT07134166
- PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated VasculitisRecruitingNCT072585241 country
- Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)RecruitingNCT06983821Phase 31 country
- Vasculitis Pregnancy RegistryRecruitingNCT025935651 country
- Longitudinal Study for Central Nervous System VasculitisRecruitingNCT057344042 countries
- Longitudinal Study for Relapsing PolychondritisRecruitingNCT049195381 country
- Clinical Transcriptomics in Systemic Vasculitis (CUTIS)RecruitingNCT030043262 countries
- One-Time DNA Study for VasculitisRecruitingNCT012413053 countries
- Generative AI Impact on Rheumatoid Arthritis Complications DiagnosisRecruitingNCT073018921 country
- Vascular Lab Resource (VLR) BiorepositoryRecruitingNCT056289481 country
- MEMRI and Kidney DiseaseRecruitingNCT066986141 country
- Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.RecruitingNCT03290456Not applicable1 country
- Prospective Longitudinal Cohort Study of Vasculitis PatientsRecruitingNCT044133311 country
- A Real-World Registry of Chronic Wounds and UlcersRecruitingNCT022807331 country
- Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory DiseasesRecruitingNCT053833391 country
- Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAVNot yet recruitingNCT06986018Early Phase 11 country
- A Study of OL-108 in Relapsed/Refractory Autoimmune DiseasesRecruitingNCT06980597Phase 11 country
- UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune DiseasesNot yet recruitingNCT06978738Phase 11 country
- Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated VasculitisRecruitingNCT06611696Phase 41 country
- Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune DiseasesRecruitingNCT06685042Phase 1/21 country
- AYLo - AutoimmunitY and Loss of yRecruitingNCT066960271 country
- Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory DiseasesRecruitingNCT059043011 country
- BCMA-CD19 CAR-T Therapy for Refractory Autoimmune DiseasesRecruitingNCT06794008Phase 21 country
- Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)Not yet recruitingNCT06226662Phase 2
- Prediction of Risk of Vascular Structural Damage in Patients with Large Vessel Vasculitis (LVV) Based on PET/MRA Image Evaluation SystemRecruitingNCT068247141 country
- Early-access Avacopan in Real-world ANCA-associated VasculitisRecruitingNCT067948271 country
- Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)RecruitingNCT067797991 country
- Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)RecruitingNCT050171421 country
- Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune DiseasesEnrolling by invitationNCT05859997Not applicable1 country
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)RecruitingNCT06350110Phase 1/21 country
- Rare AutoImmune SElf-management Programme DevelopmentRecruitingNCT066428701 country
- ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUSRecruitingNCT065930411 country